Cargando…
Response Commentary: Exosomes vs microvesicles in hematological malignancies
Autores principales: | Whiteside, Theresa L., Boyiadzis, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628142/ https://www.ncbi.nlm.nih.gov/pubmed/28776566 http://dx.doi.org/10.1038/leu.2017.248 |
Ejemplares similares
-
Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia
por: Hong, Chang-Sook, et al.
Publicado: (2014) -
Chemotherapy Promotes Release of Exosomes Which Upregulate Cholesterol Synthesis and Chemoresistance in AML Blasts
por: Hong, Chang-Sook, et al.
Publicado: (2021) -
Circulating exosomes carrying an immunosuppressive cargo may interfere with adoptive cell therapies in leukemia
por: Boyiadzis, Michael, et al.
Publicado: (2015) -
Biologically-active exosomes in plasma of AML patients inhibit innate immunity and promote leukemia progression
por: Boyiadzis, Michael, et al.
Publicado: (2015) -
Isolation and Characterization of CD34+ Blast-Derived Exosomes in Acute Myeloid Leukemia
por: Hong, Chang Sook, et al.
Publicado: (2014)